Michael Thomas Heffernan is an entrepreneur and businessperson who founded 5 companies, including: Collegium Pharmaceutical, Inc., Avenge Bio, Inc. and PreCision Dermatology, Inc. and who has been at the head of 9 different companies. Presently, he is Chairman for Collegium Pharmaceutical, Inc. (which he founded in 2002), Chairman at Indalo Therapeutics, Inc., Chairman of Carisma Therapeutics, Inc. and President & Director at Avenge Bio, Inc. (which he founded in 2019). Mr. Heffernan is also on the board of Akebia Therapeutics, Inc., Trevi Therapeutics, Inc., Biohaven Pharmaceutical Holding Co. Ltd. and Synlogic, Inc.
He previously occupied the position of Principal at Eli Lilly & Co., Chairman of Veloxis Pharmaceuticals A, Chairman at Astellas Institute for Regenerative Medicine, President & Chief Executive Officer of Clinical Studies Ltd. (he founded the company in 1995), President, Chief Executive Officer & Director at Phymatrix Corp., President & Chief Executive Officer for Onset Dermatologics LLC (he founded the company in 2005) and Director at PreCision Dermatology, Inc.
He received an undergraduate degree from the University of Connecticut.